Thomas Wilson Eastling
CIK 1958487 · View on SEC EDGAR ↗
Insider
First SEC filing: May 6, 2026 · Latest: May 6, 2026
On this page
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net:
$0
+ 13 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| May 4, 2026 | GYRE | A | 33,271 | — | — | 33,271 Indirect | — | Acquired | (price as of 2026-08-21) |
| May 4, 2026 | GYRE | A | 92,683 | — | — | 92,683 Direct | — | Acquired | (price as of 2026-08-21) |
| May 4, 2026 | GYRE | A | 95,060 | — | — | 95,060 Direct | — | Acquired | (price as of 2026-08-21) |
| May 4, 2026 | GYRE | A | 33,271 | — | — | 33,271 Direct | — | Acquired | (price as of 2026-08-21) |
| May 4, 2026 | GYRE | A | 11,882 | — | — | 11,882 Direct | — | Acquired | (price as of 2026-08-21) |
| May 4, 2026 | GYRE | A | 47,530 | — | — | 47,530 Direct | — | Acquired | (price as of 2026-08-21) |
| May 4, 2026 | GYRE | A | 95,060 | — | — | 95,060 Direct | — | Acquired | (price as of 2026-08-21) |
| June 4, 2025 | GYRE | A | 26,000 | — | — | 26,000 Direct | — | Acquired | (price as of 2026-08-21) |
| April 16, 2025 | GYRE | M | 15,000 | — | — | 299,652 Direct | -4.77% | Disposed | (price as of 2026-08-21) |
| April 16, 2025 | GYRE | M | 15,000 | $6.93 | $103,950 | 15,000 Direct | — | Acquired | 0.9% (price as of 2026-08-21) |
| Aug. 14, 2024 | GYRE | A | 26,000 | — | — | 26,000 Direct | — | Acquired | (price as of 2026-08-21) |
| Oct. 31, 2023 | GYRE | A | 1,866 | — | — | 1,866 Direct | — | Acquired | (price as of 2026-08-21) |
| Oct. 31, 2023 | GYRE | A | 314,652 | — | — | 314,652 Direct | — | Acquired | (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| May 4, 2026 | GYRE | Stock Option (Right to Buy) | Common Stock (33,271) | $0.32 | June 7, 2028 | 33,271 | Acquired |
| May 4, 2026 | GYRE | Stock Option (Right to Buy) | Common Stock (92,683) | $5.98 | Nov. 12, 2034 | 92,683 | Acquired |
| May 4, 2026 | GYRE | Stock Option (Right to Buy) | Common Stock (95,060) | $2.34 | Jan. 23, 2032 | 95,060 | Acquired |
| May 4, 2026 | GYRE | Stock Option (Right to Buy) | Common Stock (33,271) | $2.00 | June 9, 2031 | 33,271 | Acquired |
| May 4, 2026 | GYRE | Stock Option (Right to Buy) | Common Stock (11,882) | $2.00 | Dec. 17, 2030 | 11,882 | Acquired |
| May 4, 2026 | GYRE | Stock Option (Right to Buy) | Common Stock (47,530) | $0.93 | Jan. 12, 2030 | 47,530 | Acquired |
| May 4, 2026 | GYRE | Stock Option (Right to Buy) | Common Stock (95,060) | $0.32 | June 7, 2028 | 95,060 | Acquired |
| June 4, 2025 | GYRE | Stock Option (Right to Buy) | Common Stock (26,000) | $8.58 | June 4, 2035 | 26,000 | Acquired |
| April 16, 2025 | GYRE | Stock Option (Right to Buy) | Common Stock (15,000) | $6.93 | Oct. 31, 2033 | 15,000 | Disposed |
| Aug. 14, 2024 | GYRE | Stock Option (Right to Buy) | Common Stock (26,000) | $9.98 | Aug. 14, 2034 | 26,000 | Acquired |
| Oct. 31, 2023 | GYRE | Stock Option (Right to Buy) | Common Stock (1,866) | $6.93 | Oct. 31, 2033 | 1,866 | Acquired |
| Oct. 31, 2023 | GYRE | Stock Option (Right to Buy) | Common Stock (314,652) | $6.93 | Oct. 31, 2033 | 314,652 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).